#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4303083	F	IC50 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).	Chlorocebus sabaeus	57	ALA4303773	organism-based format	SARS-CoV-2 Screening Data 2020-21
2.	ALA4303085	F	AUC (viral infection %) for SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).	Chlorocebus sabaeus	57	ALA4303773	organism-based format	SARS-CoV-2 Screening Data 2020-21
3.	ALA4303092	F	Overall antiviral activity against SARS-CoV-2 (isolate France/IDF0372/2020) in the Vero E6 cell line at 48 h based on three assays 1) detection of viral RNA by qRT-PCR (targeting the N-gene), 2) plaque assay using lysate 3 days after addition of compound by crystal violet staining 3) Cell viability (cytotoxicity) measuring percentage viable Vero E6 cells 48 h after compound addition by AlamarBlue assay.	Chlorocebus sabaeus	59	ALA4303773	organism-based format	SARS-CoV-2 Screening Data 2020-21
4.	ALA4303778	F	IC90 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line by measuring infectious viral titer of supernatent from compound-treated Vero E6 cells by Median Tissue Culture Infectious Dose (TCID)50 by the method of Reed and Muench	Chlorocebus sabaeus	3	ALA4303773	organism-based format	SARS-CoV-2 Screening Data 2020-21
5.	ALA4303805	F	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging	Homo sapiens	5,612	ALA4303101	organism-based format	SARS-CoV-2 Screening Data 2020-21
6.	ALA4303806	F	Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging	Homo sapiens	67	ALA4303101	organism-based format	SARS-CoV-2 Screening Data 2020-21
7.	ALA4303810	F	Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)	Homo sapiens	1,629	ALA4303122	organism-based format	SARS-CoV-2 Screening Data 2020-21
8.	ALA4303811	F	Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in Vero cells at MOI 0.08 after 48 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)	Chlorocebus sabaeus	32	ALA4303122	organism-based format	SARS-CoV-2 Screening Data 2020-21
9.	ALA4303812	F	Antiviral activity against SARS-CoV-2 (viral titer) measured by plaque assay in Vero cells at MOI 0.0125 after 24 hr	Chlorocebus sabaeus	48	ALA4303084	organism-based format	SARS-CoV-2 Screening Data 2020-21
10.	ALA4303815	F	Determination of antiviral efficacy in high-content imaging assay in Vero E6 cells infected with SARS-CoV-2 (USA-WA1/2020 isolate) at MOI 0.75 after 24 hrs	Chlorocebus sabaeus	18	ALA4303082	organism-based format	SARS-CoV-2 Screening Data 2020-21
11.	ALA4303816	F	Inhibition of SARS-CoV-2 pseudoparticle entry in Huh-7 cells, assessed by luciferase assay after 72 hrs	Homo sapiens	7	ALA4303121	organism-based format	SARS-CoV-2 Screening Data 2020-21
12.	ALA4303817	F	Inhibition of SARS-CoV-2 pseudoparticle entry in human lung Airway Chip at reported drug Cmax, assessed by qRT-PCR after 48 hrs	Homo sapiens	7	ALA4303121	organism-based format	SARS-CoV-2 Screening Data 2020-21
13.	ALA4303819	F	Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs	Chlorocebus sabaeus	1,518	ALA4303097	organism-based format	SARS-CoV-2 Screening Data 2020-21
14.	ALA4303820	F	Antiviral efficacy against SARS-CoV-2 (strain BavPat1) in Vero E6 cells assessed by inhibition of viral RNA replication measured by RT-PCR after 2 days	Chlorocebus sabaeus	17	ALA4303097	organism-based format	SARS-CoV-2 Screening Data 2020-21
15.	ALA4303823	F	IC50 determination at MOI 0.004 using CellTiter- Glo (CTG) assay, performed 3 days post-infection in SARS-CoV-2 infected Vero E6 cells	Chlorocebus sabaeus	19	ALA4303087	organism-based format	SARS-CoV-2 Screening Data 2020-21
16.	ALA4303826	F	IC50 determination at MOI 0.01 using CellTiter- Glo (CTG) assay, performed 3 days post-infection in SARS-CoV-2 infected Vero E6 cells	Chlorocebus sabaeus	19	ALA4303087	organism-based format	SARS-CoV-2 Screening Data 2020-21
17.	ALA4303829	F	Reduction of viral mRNA (RdRp and N) in SARS-CoV-2 infected Vero E6 cells (at MOI 0.1) after 24 hrs	Chlorocebus sabaeus	2	ALA4303087	organism-based format	SARS-CoV-2 Screening Data 2020-21
18.	ALA4303830	F	Reduction of viral replication in SARS-CoV-2 infected Vero E6 cells (at MOI 0.1) after 24 hrs by TCID50 assay	Chlorocebus sabaeus	6	ALA4303087	organism-based format	SARS-CoV-2 Screening Data 2020-21
19.	ALA4303831	F	Reduction of SARS-CoV-2 infection by time of addition assay, with 50uM hydroxychloroquine administered at -2hrs, 0 hrs and 2hrs post-infection	Chlorocebus sabaeus	1	ALA4303087	organism-based format	SARS-CoV-2 Screening Data 2020-21
20.	ALA4513082	F	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging	Chlorocebus sabaeus	7,212	ALA4495565	organism-based format	SARS-CoV-2 Screening Data 2020-21